20
Amsa Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LURASIDONE HYDROCHLORIDE, with a corresponding US DMF Number 27898.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2014, and payment made on January 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II